Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Adverse drug reactions

Lack of evidence over ketamine’s long-term safety

Acute side effects are common in studies of patients who have received ketamine for depression and more research is needed into long-term outcomes, researchers find.

Hospital staff holding ketamine ampoule

Source: Voisin / Phanie / Science Photo Library

Researchers conclude that large-scale clinical trials with multiple doses of ketamine, long-term follow-up and reporting of all side effects are needed to assess the safety of ketamine before it is used as a widespread treatment for depression.

Over the past 15 years, there have been many reports into the efficacy of ketamine for treating depression, but very few original studies of its safety.

In The Lancet Psychiatry (online, 27 July 2017), researchers performed a systematic review of 60 studies including 899 patients who had received ketamine[1].

The researchers found that acute side effects were common and included headache, dizziness and elevated blood pressure, as well as psychiatric side effects such as anxiety. They also observed that the majority of side effects were associated with ketamine given intravenously and occurred immediately after single-dose administration.

Most studies were not placebo-controlled and only 12 (20%) assessed long-term side effects.

The researchers say that large-scale clinical trials with multiple doses of ketamine, long-term follow-up and reporting of all side effects are needed to assess the safety of ketamine before it is used as a widespread treatment for depression.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203362

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Hospital staff holding ketamine ampoule

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.